Osaka Soda Co (4046) Corporate presentation summary
Event summary combining transcript, slides, and related documents.
Corporate presentation summary
1 Sep, 2026Key messages and strategic focus
Emphasizes strong business momentum, sustainable growth drivers, and a clear path to shareholder value creation.
Focus areas include investment highlights, key growth drivers, growth strategy, capital strategy, and FY2026 forecast.
Investment highlights and business performance
Holds global niche leadership with top market share in DAP resin and epichlorohydrin rubber.
Operating profit margin reached 17.6%, among the highest in Japan's chemical industry.
Healthcare segment revenue doubled in five years, driving overall growth.
Diversified business portfolio
Portfolio includes basic chemicals, functional chemicals, healthcare, and trading/others.
Healthcare is the main growth and profit driver, with 42% of operating income.
Sales are geographically diversified, with 61% in Japan and 39% overseas.
Latest events from Osaka Soda Co
- Record quarterly profits and sales driven by robust healthcare and chemical segment growth.4046
Q1 2027 - Profits and sales rose on strong healthcare and chemicals demand; stock split set for October.4046
Q1 2025 - Operating profit jumped 41.7% on 7.6% higher sales, led by healthcare and functional chemicals.4046
Q2 2025 - Profits surged on strong healthcare demand and supply recovery; full-year outlook maintained.4046
Q3 2025 - Profits surged on healthcare growth and supply recovery, with record highs forecast for FY2025 and FY2026.4046
Q4 2025 - First-quarter profit rose 9.4% year-on-year, driven by healthcare and basic chemicals growth.4046
Q1 2026 - Profits rose sharply despite lower sales, with upward guidance and enhanced shareholder returns.4046
Q2 2026 - Operating profit surged 21.6% and net profit rose 34.0% despite a 1.3% sales decline.4046
Q3 2026 - Record profits and sales driven by Basic Chemicals and Healthcare, with robust cash flow and new growth plans.4046
Q4 2026